213 related articles for article (PubMed ID: 2504288)
21. Tolbutamide- and diazoxide-sensitive K+ channel in neurons of substantia nigra pars reticulata.
Schwanstecher C; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):113-7. PubMed ID: 8377835
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the effects of cromakalim (BRL 34915) and diazoxide on membrane potential, [Ca2+]i and ATP-sensitive potassium currents in insulin-secreting cells.
Dunne MJ; Yule DI; Gallacher DV; Petersen OH
J Membr Biol; 1990 Mar; 114(1):53-60. PubMed ID: 2181144
[TBL] [Abstract][Full Text] [Related]
23. Tolbutamide-sensitivity of the adenosine 5'-triphosphate-dependent K+ channel in mouse pancreatic B-cells.
Panten U; Heipel C; Rosenberger F; Scheffer K; Zünkler BJ; Schwanstecher C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):566-74. PubMed ID: 2090953
[TBL] [Abstract][Full Text] [Related]
24. Cell-type specific depression of neuronal excitability in rat hippocampus by activation of ATP-sensitive potassium channels.
Griesemer D; Zawar C; Neumcke B
Eur Biophys J; 2002 Oct; 31(6):467-77. PubMed ID: 12355256
[TBL] [Abstract][Full Text] [Related]
25. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
Mariot P; Gilon P; Nenquin M; Henquin JC
Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues.
Becker B; Antoine MH; Nguyen QA; Rigo B; Cosgrove KE; Barnes PD; Dunne MJ; Pirotte B; Lebrun P
Br J Pharmacol; 2001 Sep; 134(2):375-85. PubMed ID: 11564656
[TBL] [Abstract][Full Text] [Related]
27. Multiple sulfonylurea-sensitive potassium channels: a novel subtype modulated by dopamine.
Lin YJ; Greif GJ; Freedman JE
Mol Pharmacol; 1993 Nov; 44(5):907-10. PubMed ID: 8246912
[TBL] [Abstract][Full Text] [Related]
28. Activation of sulphonylurea-sensitive channels and the NO-cGMP pathway decreases the heart rate response to sympathetic nerve stimulation.
Mohan RM; Paterson DJ
Cardiovasc Res; 2000 Jul; 47(1):81-9. PubMed ID: 10869533
[TBL] [Abstract][Full Text] [Related]
29. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
[TBL] [Abstract][Full Text] [Related]
30. Effects of potassium channel openers and their antagonists on rat locus coeruleus neurones.
Finta EP; Harms L; Sevcik J; Fischer HD; Illes P
Br J Pharmacol; 1993 Jun; 109(2):308-15. PubMed ID: 8358535
[TBL] [Abstract][Full Text] [Related]
31. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.
Wolleben CD; Sanguinetti MC; Siegl PK
J Mol Cell Cardiol; 1989 Aug; 21(8):783-8. PubMed ID: 2506353
[TBL] [Abstract][Full Text] [Related]
32. Identification of an ATP-sensitive potassium channel current in rat striatal cholinergic interneurones.
Lee K; Dixon AK; Freeman TC; Richardson PJ
J Physiol; 1998 Jul; 510 ( Pt 2)(Pt 2):441-53. PubMed ID: 9705995
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
Garlid KD; Paucek P; Yarov-Yarovoy V; Murray HN; Darbenzio RB; D'Alonzo AJ; Lodge NJ; Smith MA; Grover GJ
Circ Res; 1997 Dec; 81(6):1072-82. PubMed ID: 9400389
[TBL] [Abstract][Full Text] [Related]
34. ATP-sensitive K-channels in HIT T15 beta-cells studied by patch-clamp methods, 86Rb efflux and glibenclamide binding.
Niki I; Kelly RP; Ashcroft SJ; Ashcroft FM
Pflugers Arch; 1989 Oct; 415(1):47-55. PubMed ID: 2516306
[TBL] [Abstract][Full Text] [Related]
35. Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride.
Bijlstra PJ; Russel FG; Thien T; Lutterman JA; Smits P
Horm Metab Res; 1996 Sep; 28(9):512-6. PubMed ID: 8911989
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
Findlay I
J Pharmacol Exp Ther; 1992 May; 261(2):540-5. PubMed ID: 1578371
[TBL] [Abstract][Full Text] [Related]
37. Effects of K(ATP) channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts.
Jilkina O; Kuzio B; Grover GJ; Kupriyanov VV
J Mol Cell Cardiol; 2002 Apr; 34(4):427-40. PubMed ID: 11991732
[TBL] [Abstract][Full Text] [Related]
38. ATP-dependent K+ channels in renal ischemia reperfusion injury.
Rahgozar M; Willgoss DA; Gobé GC; Endre ZH
Ren Fail; 2003 Nov; 25(6):885-96. PubMed ID: 14669848
[TBL] [Abstract][Full Text] [Related]
39. Tolbutamide as mimic of glucose on beta-cell electrical activity. ATP-sensitive K+ channels as common pathway for both stimuli.
Cook DL; Ikeuchi M
Diabetes; 1989 Apr; 38(4):416-21. PubMed ID: 2647550
[TBL] [Abstract][Full Text] [Related]
40. Diazoxide- and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line.
Harvey J; Ashford ML
Br J Pharmacol; 1998 Aug; 124(7):1557-65. PubMed ID: 9723971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
